首页> 美国卫生研究院文献>NPG Open Access >Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma
【2h】

Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma

机译:3p21.3定位的BLU基因在鼻咽癌中的抗血管生成途径相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Zinc-finger, MYND-type containing 10 (ZMYND10), or more commonly called BLU, expression is frequently downregulated in nasopharyngeal carcinoma (NPC) and many other tumors due to promoter hypermethylation. Functional evidence shows that the BLU gene inhibits tumor growth in animal assays, but the detailed molecular mechanism responsible for this is still not well understood. In current studies, we find that 93.5% of early-stage primary NPC tumors show downregulated BLU expression. Using a PCR array, overexpression of the BLU gene was correlated to the angiogenesis network in NPC cells. Moreover, expression changes of the MMP family, VEGF and TSP1, were often detected in different stages of NPC, suggesting the possibility that BLU may be directly involved in the microenvironment and anti-angiogenic activity in NPC development. Compared with vector-alone control cells, BLU stable transfectants, derived from poorly-differentiated NPC HONE1 cells, suppress VEGF165, VEGF189 and TSP1 expression at both the RNA and protein levels, and significantly reduce the secreted VEGF protein in these cells, reflecting an unknown regulatory mechanism mediated by the BLU gene in NPC. Cells expressing BLU inhibited cellular invasion, migration and tube formation. These in vitro results were further confirmed by in vivo tumor suppression and a matrigel plug angiogenesis assay in nude mice. Tube-forming ability was clearly inhibited, when the BLU gene is expressed in these cells. Up to 70–90% of injected tumor cells expressing increased exogenous BLU underwent cell death in animal assays. Overexpressed BLU only inhibited VEGF165 expression in differentiated squamous NPC HK1 cells, but also showed an anti-angiogenic effect in the animal assay, revealing a complicated mechanism regulating angiogenesis and the microenvironment in different NPC cell lines. Results of these studies indicate that alteration of BLU gene expression influences anti-angiogenesis pathways and is important for the development of NPC.
机译:含锌指的MYND型含10(ZMYND10),或更常见的称为BLU,由于启动子甲基化过度,在鼻咽癌(NPC)和许多其他肿瘤中的表达经常下调。功能性证据表明,BLU基因在动物实验中抑制肿瘤的生长,但是造成这种现象的详细分子机制仍未得到很好的理解。在当前的研究中,我们发现93.5%的早期原发性NPC肿瘤显示BLU表达下调。使用PCR阵列,BLU基因的过表达与NPC细胞中的血管生成网络相关。此外,经常在NPC的不同阶段检测到MMP家族,VEGF和TSP1的表达变化,提示BLU可能直接参与NPC发育的微环境和抗血管生成活性。与单独载体的对照细胞相比,源自差分化的NPC HONE1细胞的BLU稳定转染子在RNA和蛋白质水平上均抑制VEGF165,VEGF189和TSP1的表达,并显着减少这些细胞中分泌的VEGF蛋白,这是未知的NPC中BLU基因介导的调控机制。表达BLU的细胞抑制细胞侵袭,迁移和管形成。通过体内肿瘤抑制和裸鼠中的基质胶栓塞血管生成测定法进一步证实了这些体外结果。当在这些细胞中表达BLU基因时,显着抑制了成管能力。在动物实验中,多达70-90%的表达增加的外源 BLU 的注射肿瘤细胞经历了细胞死亡。过表达的BLU仅抑制分化的NPC HK1细胞中VEGF165的表达,而且在动物实验中显示出抗血管生成作用,揭示了调节血管生成和不同NPC细胞系中微环境的复杂机制。这些研究结果表明, BLU 基因表达的改变会影响抗血管生成途径,对鼻咽癌的发展具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号